BioSpace News Archive

Deals

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

EyePoint Pharmaceuticals, Inc., a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

February 20, 2020
·
4 min read
Pharm Country

Trevi Therapeutics to Present at SVB Leerink Healthcare Conference

Trevi Therapeutics, Inc. announced that management will present a Company overview, as well as host investor meetings, at the SVB Leerink 2020 Healthcare Conference

February 20, 2020
·
2 min read
FDA

Baudax Bio Announces FDA Approval of ANJESO™ for the Management of Moderate to Severe Pain

Baudax Bio, Inc. announced that the U.S. Food and Drug Administration has approved the New Drug Application for ANJESO™, which is indicated for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics..

February 20, 2020
·
16 min read